Authors:
JOSEPH E
HYACINTHE M
LYMAN GH
BUSCH C
DEMPS L
REINTGEN DS
COX CE
Citation: E. Joseph et al., EVALUATION OF AN INTENSIVE STRATEGY FOR FOLLOW-UP AND SURVEILLANCE OFPRIMARY BREAST-CANCER, Annals of surgical oncology, 5(6), 1998, pp. 522-528
Authors:
BROBEIL A
BERMAN C
CRUSE CW
DECONTI R
CANTOR A
LYMAN GH
JOSEPH E
RAPAPORT D
WELLS K
REINTGEN DS
Citation: A. Brobeil et al., EFFICACY OF HYPERTHERMIC ISOLATED LIMB PERFUSION FOR EXTREMITY-CONFINED RECURRENT MELANOMA, Annals of surgical oncology, 5(4), 1998, pp. 376-383
Authors:
BROECKEL JA
JACOBSEN PB
HORTON J
BALDUCCI L
LYMAN GH
Citation: Ja. Broeckel et al., CHARACTERISTICS AND CORRELATES OF FATIGUE AFTER ADJUVANT CHEMOTHERAPYFOR BREAST-CANCER, Journal of clinical oncology, 16(5), 1998, pp. 1689-1696
Authors:
EXTERMANN M
OVERCASH J
LYMAN GH
PARR J
BALDUCCI L
Citation: M. Extermann et al., COMORBIDITY AND FUNCTIONAL STATUS ARE INDEPENDENT IN OLDER CANCER-PATIENTS, Journal of clinical oncology, 16(4), 1998, pp. 1582-1587
Authors:
SHIVERS SC
WANG XN
LI WG
JOSEPH E
MESSINA J
GLASS LF
DECONTI R
CRUSE CW
BERMAN C
FENSKE NA
LYMAN GH
REINTGEN DS
Citation: Sc. Shivers et al., MOLECULAR STAGING OF MALIGNANT-MELANOMA - CORRELATION WITH CLINICAL OUTCOME, JAMA, the journal of the American Medical Association, 280(16), 1998, pp. 1410-1415
Authors:
JACOBSEN PB
AZZARELLO LM
HANN DM
LYMAN GH
Citation: Pb. Jacobsen et al., PREVALENCE, PREDICTORS, AND COURSE OF FATIGUE DURING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER, Psychosomatic medicine, 60(1), 1998, pp. 120-121
Authors:
COX CE
PENDAS S
COX JM
JOSEPH E
SHONS AR
YEATMAN T
KU NN
LYMAN GH
BERMAN C
HADDAD F
REINTGEN DS
Citation: Ce. Cox et al., GUIDELINES FOR SENTINEL NODE BIOPSY AND LYMPHATIC MAPPING OF PATIENTSWITH BREAST-CANCER, Annals of surgery, 227(5), 1998, pp. 645-653
Authors:
YEATMAN TJ
LYMAN GH
SMITH SK
REINTGEN DS
CANTOR AB
COX CE
Citation: Tj. Yeatman et al., BILATERALITY AND RECURRENCE RATES FOR LOBULAR BREAST-CANCER - CONSIDERATIONS FOR TREATMENT, Annals of surgical oncology, 4(3), 1997, pp. 198-202
Citation: Gh. Lyman et Nm. Kuderer, BASIC POPULATION AND CANCER GENETICS AND THEIR USE IN THE ASSESSMENT OF CANCER RISK, European journal of cancer, 33(13), 1997, pp. 2160-2166
Authors:
KUMAR NB
ALLEN K
CANTOR A
COX CE
GREENBERG H
SHAH S
LYMAN GH
Citation: Nb. Kumar et al., WEIGHT-GAIN ASSOCIATED WITH ADJUVANT TAMOXIFEN THERAPY IN STAGE-I ANDSTAGE-II BREAST-CANCER - FACT OR ARTIFACT, Breast cancer research and treatment, 44(2), 1997, pp. 135-143
Authors:
ALBERTINI JJ
LYMAN GH
COX C
YEATMAN T
BALDUCCI L
KU NN
SHIVERS S
BERMAN C
WELLS K
RAPAPORT D
SHONS A
HORTON J
GREENBERG H
NICOSIA S
CLARK R
CANTOR A
REINTGEN DS
Citation: Jj. Albertini et al., LYMPHATIC MAPPING AND SENTINEL NODE BIOPSY IN THE PATIENT WITH BREAST-CANCER, JAMA, the journal of the American Medical Association, 276(22), 1996, pp. 1818-1822
Citation: Gh. Lyman et al., THRESHOLDS FOR THE USE OF RECOMBINANT HUMAN COLONY-STIMULATING FACTORS (CSFS) BASED ON REVISED COST ESTIMATES INCORPORATING INDIRECT MEDICAL, NONMEDICAL AND INTANGIBLE COST CONSIDERATIONS, Blood, 88(10), 1996, pp. 1373-1373
Citation: Mh. Werner et al., THE INCREASING INCIDENCE OF MALIGNANT GLIOMAS AND PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA IN THE ELDERLY, Cancer, 76(9), 1995, pp. 1634-1642
Authors:
SCHAPIRA DV
WOLFF PA
KUMAR NB
ANDERSON JJB
AZIZ NM
LYMAN GH
SWANSON M
Citation: Dv. Schapira et al., THE EFFECT OF WEIGHT-LOSS ON ESTIMATED BREAST-CANCER RISK AND SEX-HORMONE LEVELS, Oncology Reports, 1(3), 1994, pp. 613-617
Citation: Gh. Lyman et L. Balducci, THE EFFECT OF CHANGING DISEASE RISK ON CLINICAL REASONING, Journal of general internal medicine, 9(9), 1994, pp. 488-495